Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2025-03-04

FDA Approved: ERIBULIN MESYLATE — Original Application (Sun Pharmaceutical Industries Limited)

View source ↗

Summary

FDA approved Sun Pharmaceutical Industries Limited's original ANDA for eribulin mesylate, confirming a generic version of the cancer drug. The approval aligns w…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ERIBULIN MESYLATE (Eribulin mesylate)

Snippet

ORIG AP for ERIBULIN MESYLATE (ERIBULIN MESYLATE)